Who
Jeremy Curnock Cook
Director
Company insider
Files Form 4 as: Director, Avita Medical; Chairman of the Board, Armata Pharmaceuticals; Director, Osteologix; Director, Sirna Therapeutics.
In numbers
- Trades disclosed
- 59
- Buys
- 7
- Sells
- 2
- Bought
- $1.1M
- Sold
- $62K
- Companies
- 4
- Companies where not an officer
- 3
- First trade
- 8 May 2006
- Last trade
- 20 Jan 2026
- Last filed
- 4 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 20 Jan 2026filed 4 Jun 2026 | RCEL Avita MedicalMedical Devices | SEC FORM 4 Code A | —22,214 | filing |
| 20 Jan 2026filed 4 Jun 2026 | RCEL Avita Medicaloption or derivative · Medical Devices | SEC FORM 4 Code A | —16,133 at $0.00 | filing |
| 20 Jan 2026filed 4 Jun 2026 | RCEL Avita Medicaloption or derivative · Medical Devices | SEC FORM 4 Code A | —16,133 at $0.00 | filing |
| 20 Jan 2026filed 4 Jun 2026 | RCEL Avita MedicalMedical Devices | SEC FORM 4 Code A | —22,214 | filing |
| 21 Jan 2025filed 5 Jun 2025 | RCEL Avita Medicaloption or derivative · Medical Devices | SEC FORM 4 Code A | —4,295 at $0.00 | filing |
| 21 Jan 2025filed 5 Jun 2025 | RCEL Avita MedicalMedical Devices | SEC FORM 4 Code A | —10,022 | filing |
| 5 Jun 2024filed 6 Jun 2024 | RCEL Avita Medicaloption or derivative · Medical Devices | SEC FORM 4 Code A | —3,943 at $0.00 | filing |
| 5 Jun 2024filed 6 Jun 2024 | RCEL Avita MedicalMedical Devices | SEC FORM 4 Code A | —9,200 | filing |
| 21 Dec 2023filed 22 Dec 2023 | RCEL Avita MedicalMedical Devices | SEC FORM 4 Sold | $31K2,500 at $12.49 | filing |
| 13 Dec 2023filed 14 Dec 2023 | RCEL Avita MedicalMedical Devices | SEC FORM 4 Sold | $31K2,518 at $12.27 | filing |
| 6 Jun 2023filed 8 Jun 2023 | RCEL Avita Medicaloption or derivative · Medical Devices | SEC FORM 4 Code A | —2,646 at $0.00 | filing |
| 6 Jun 2023filed 8 Jun 2023 | RCEL Avita MedicalMedical Devices | SEC FORM 4 Code A | —6,175 | filing |
| 12 Dec 2022filed 14 Dec 2022 | RCEL Avita Medicaloption or derivative · Medical Devices | SEC FORM 4 Code A | —5,395 at $0.00 | filing |
| 12 Dec 2022filed 14 Dec 2022 | RCEL Avita MedicalMedical Devices | SEC FORM 4 Code A | —12,589 | filing |
| 22 Dec 2021filed 27 Dec 2021 | RCEL Avita Medicaloption or derivative · Medical Devices | SEC FORM 4 Code A | —2,550 at $0.00 | filing |
| 22 Dec 2021filed 27 Dec 2021 | RCEL Avita MedicalMedical Devices | SEC FORM 4 Code A | —4,350 | filing |
| 22 May 2019filed 24 May 2019 | ARMP Armata Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —27,383 at $0.00 | filing |
| 9 May 2019filed 14 Feb 2020 | ARMP Armata Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code J | $563.0M46,666 at $12,065.46 | filing |
| 22 Mar 2018filed 26 Mar 2018 | ARMP Armata PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $200K181,820 at $1.10 | filing |
| 19 Sep 2017filed 26 Mar 2018 | ARMP Armata PharmaceuticalsBiotechnology | SEC FORM 4 Bought | —105,015 | filing |
News
Ambu A/S (OTCMKTS:AMBBY) & Avita Medical (NASDAQ:RCEL) Head to Head AnalysisRCEL · tickerreport.com · 14 Oct 2026
0 headlines in the last 90 days name Jeremy Curnock Cook; 1 article from the last 14 days about the 2 companies they traded most, at most three about any one of them.